Innovative pharmaceutical firms boosting R&D spending

Published: 2013-07-24 06:58:00

Updated: 2013-07-24 06:58:00

Twenty eight innovative drug firms have been spending more on research and development (R&D) projects to strengthen their technology leadership, industrial report showed Monday.

According to a report released by the Korea Health Industry Development Institute (KHIDI), the combined R&D spending...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK